Oscar Health Inc.

NYSE: OSCR · Real-Time Price · USD
15.63
0.95 (6.47%)
At close: Aug 15, 2025, 3:59 PM
15.62
-0.06%
After-hours: Aug 15, 2025, 05:07 PM EDT

Oscar Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
2.86B 3.05B 2.39B 2.42B 2.22B 2.14B 1.43B 1.44B 1.52B 1.47B 1.04B 1.02B 1.06B 1.01B 520.33M 462.19M 549.75M 388.69M
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
-3.05B 3.05B 2.39B 2.42B 2.22B 2.14B 1.43B 1.44B 1.52B 1.47B 1.04B 1.02B 1.06B 1.01B 520.33M 462.19M 549.75M 388.69M
Operating Income
-221.57M 288.21M -153.69M -52.31M 60.95M 178.48M -150.64M -64.79M -14.26M -37.61M -227.28M -195.16M -111.83M -75.8M -198.35M -212.08M -72.73M -87.92M
Interest Income
n/a n/a n/a n/a n/a n/a n/a 1.68M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-233.54M 288.21M -153.69M -52.31M 60.95M 178.48M -150.64M -64.79M -14.26M -37.61M -227.28M -195.16M -111.83M -75.8M -198.35M -212.08M -72.73M -87.92M
Net Income
-228.36M 275.27M -153.55M -54.6M 56.21M 177.37M -150.03M -65.4M -15.53M -39.77M -226.05M -192.91M -112.16M -75.15M -199.42M -211.48M -73.32M -88.88M
Selling & General & Admin
534.49M 482.76M 466.58M 459.52M 435.14M 394.7M 85.61M 325.82M 337.83M 396.98M 75.81M 78.56M 80.75M 74.66M 89.84M 60M 51.17M 64.57M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
2.55B 2.28B 2.08B 2.02B 1.72B 1.57B 1.5B 1.18B 1.2B 1.11B 1.19B 1.14B 1.09B 1.01B 628.84M 614.27M 571.32M 412.04M
Operating Expenses
3.09B 2.76B 2.55B 2.48B 2.16B 1.96B 1.58B 1.5B 1.54B 1.51B 1.26B 1.21B 1.17B 1.09B 718.68M 674.27M 622.48M 476.61M
Interest Expense
5.85M 5.99M 6.03M 5.82M 5.99M 5.9M 6.22M 6.13M 6.12M 6.14M 6.13M 6.13M 6.14M 4.22M 397K 398K 228K 3.7M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
3.09B 2.76B 2.55B 2.48B 2.16B 1.96B 1.58B 1.5B 1.54B 1.51B 1.26B 1.21B 1.17B 1.09B 718.68M 674.27M 622.48M 476.61M
Income Tax Expense
-5.04M 12.71M -404K 2.08M 4.64M 996K -806K 915K 1.16M 2.02M -715K -1.61M 290K 1.52M -111K -597K 589K 965K
Shares Outstanding (Basic)
253.42M 251.28M 240.39M 243.11M 238.67M 231.44M 227.08M 223.1M 219.4M 216.91M 215.19M 212.82M 211.31M 210.55M 209.78M 208.16M 207.48M 202.28M
Shares Outstanding (Diluted)
270.24M 305.94M 265.85M 243.11M 303.96M 293.8M 227.08M 223.1M 219.4M 216.91M 215.19M 212.82M 211.31M 210.55M 209.78M 208.16M 207.48M 205.31M
EPS (Basic)
-0.89 1.10 -0.62 -0.22 0.24 0.77 -0.66 -0.29 -0.07 -0.18 -1.05 -0.91 -0.53 -0.37 -0.95 -1.02 -0.35 -0.44
EPS (Diluted)
-0.89 0.92 -0.62 -0.22 0.18 0.60 -0.66 -0.29 -0.07 -0.18 -1.05 -0.91 -0.53 -0.37 -0.95 -1.02 -0.35 -0.43
EBITDA
-220.59M 300.94M -138.43M -39M 74.54M 192.19M -136.69M -49.47M 681K -26.53M -217.41M -184.98M -102M -67.78M -193.99M -208.03M -68.92M -80.82M
EBIT
-230.48M 294.2M -147.66M -46.5M 66.94M 184.38M -144.43M -58.66M -8.14M -31.47M -221.14M -189.04M -105.69M -71.58M -197.96M -211.68M -72.51M -84.22M
Depreciation & Amortization
6.97M 6.73M 9.23M 7.5M 7.6M 7.81M 7.74M 9.19M 8.82M 4.94M 3.73M 4.06M 3.69M 3.8M 3.97M 3.65M 3.59M 3.4M